WallStreetZenWallStreetZen

NASDAQ: LTRN
Lantern Pharma Inc Stock Ownership - Who owns Lantern Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lantern Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aaron Gl Fletcher10% Owner2025-06-137,206$3.09
$22.27kSell
Leslie W. Kreis10% Owner2025-06-134,354$3.09
$13.45kSell
Leslie W. Kreis10% Owner2025-06-1312,319$3.09
$38.07kSell
Leslie W. Kreis10% Owner2025-06-131,903$3.09
$5.88kSell
Leslie W. Kreis10% Owner2025-06-1314,218$3.09
$43.93kSell
Leslie W. Kreis10% Owner2025-06-137,206$3.09
$22.27kSell
Aaron Gl Fletcher10% Owner2025-06-134,354$3.09
$13.45kSell
Aaron Gl Fletcher10% Owner2025-06-1314,218$3.09
$43.93kSell
Aaron Gl Fletcher10% Owner2025-06-131,903$3.09
$5.88kSell
Aaron Gl Fletcher10% Owner2025-06-1312,319$3.09
$38.07kSell

1 of 7

LTRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LTRN insiders and whales buy or sell their stock.

LTRN Shareholders

What type of owners hold Lantern Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leslie W. Kreis27.40%2,958,970$13.52MInsider
Aaron Gl Fletcher9.96%1,075,952$4.92MInsider
Bios Capital Management LP9.96%1,075,952$4.92MInstitution
Biological Mimetics Inc9.67%1,044,000$4.77MInsider
David S. Silberstein9.67%1,044,000$4.77MInsider
Arunkumar Asaithambi4.09%441,960$2.02MInsider
Vanguard Group Inc3.37%363,720$1.66MInstitution
CM Management LLC1.85%200,000$914.00kInstitution
Green Park Golf Ventures II LLC1.22%131,697$601.86kInsider
Geode Capital Management LLC0.85%91,891$419.94kInstitution

1 of 3

LTRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LTRN20.75%62.01%Net SellingNet Selling
VTVT0.96%99.04%Net Buying
PRLD45.31%54.69%Net BuyingNet Selling
NRXP6.01%93.99%Net Buying
IPSC26.19%45.40%Net SellingNet Selling
View Top Biotech Stocks

Lantern Pharma Stock Ownership FAQ

Who owns Lantern Pharma?

Lantern Pharma (NASDAQ: LTRN) is owned by 20.75% institutional shareholders, 62.01% Lantern Pharma insiders, and 17.24% retail investors. Leslie W. Kreis is the largest individual Lantern Pharma shareholder, owning 2.96M shares representing 27.40% of the company. Leslie W. Kreis's Lantern Pharma shares are currently valued at $13.52M.

If you're new to stock investing, here's how to buy Lantern Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.